— Know what they know.
Not Investment Advice
Also trades as: 0HR2.L (LSE) · $vol 9M

CME NASDAQ

CME Group Inc.
1W: -2.8% 1M: +1.2% 3M: -6.1% YTD: +7.3% 1Y: +5.6% 3Y: +77.1% 5Y: +60.5%
$291.23
+1.94 (+0.67%)
 
Weekly Expected Move ±2.7%
$283 $291 $299 $307 $315
NASDAQ · Financial Services · Financial - Data & Stock Exchanges · Alpha Radar Neutral · Power 60 · $105.5B mcap · 357M float · 0.659% daily turnover · Short 57% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
66.3 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 12.1%  ·  5Y Avg: 12.1%
Cost Advantage
74
Intangibles
74
Switching Cost
48
Network Effect
60
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CME has a Narrow competitive edge (66.3/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 12.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$316
Low
$334
Avg Target
$353
High
Based on 2 analysts since Apr 22, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 17Sell: 5Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$343.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-23 Morgan Stanley Michael Cyprys $362 $353 -9 +25.0% $282.44
2026-04-23 Barclays $312 $316 +4 +10.6% $285.71
2026-04-10 Morgan Stanley $340 $362 +22 +22.8% $294.81
2026-02-06 UBS $280 $310 +30 +4.2% $297.38
2026-02-05 RBC Capital Ashish Sabadra $235 $302 +67 +0.5% $300.42
2026-02-05 Morgan Stanley $319 $340 +21 +15.4% $294.62
2026-02-05 Barclays Benjamin Budish $304 $312 +8 +5.9% $294.62
2026-01-15 Morgan Stanley $320 $319 -1 +16.7% $273.41
2025-12-22 Morgan Stanley Michael Cyprys $314 $320 +6 +18.9% $269.09
2025-12-12 Barclays $280 $304 +24 +11.6% $272.42
2025-10-23 Morgan Stanley Michael Cyprys $312 $314 +2 +16.5% $269.50
2025-10-23 UBS Alex Kramm $285 $280 -5 +4.6% $267.81
2025-10-23 Deutsche Bank $193 $300 +107 +11.3% $269.59
2025-10-13 Raymond James Patrick O'Shaughnessy $287 $307 +20 +13.1% $271.45
2025-10-08 Barclays $298 $280 -18 +6.2% $263.60
2025-10-01 Morgan Stanley $196 $312 +116 +18.0% $264.46
2025-09-08 UBS Alex Kramm $250 $285 +35 +8.9% $261.78
2025-07-24 Barclays Benjamin Budish $231 $298 +67 +7.5% $277.18
2025-03-10 Raymond James Patrick O'Shaughnessy $235 $287 +52 +12.7% $254.57
2024-10-24 Oppenheimer Owen Lau Initiated $258 +13.4% $227.43
2024-10-24 Barclays Benjamin Budish $209 $231 +22 +1.7% $227.14
2024-10-03 Citigroup Christopher Allen $280 $250 -30 +11.8% $223.57
2024-09-26 RBC Capital Ashish Sabadra Initiated $235 +7.6% $218.47
2024-09-03 Bank of America Securities Craig Siegenthaler Initiated $177 -18.0% $215.74
2024-07-25 Deutsche Bank Brian Bedell $210 $193 -17 -3.0% $198.92
2024-07-25 Piper Sandler Patrick Moley $250 $225 -25 +12.8% $199.38
2024-07-25 Barclays Benjamin Budish $228 $209 -19 +6.0% $197.25
2024-06-05 UBS Alex Kromm $240 $250 +10 +22.7% $203.78
2024-04-25 Rosenblatt Securities Andrew Bond $171 $187 +16 -12.0% $212.59
2024-04-25 Barclays Benjamin Budish Initiated $228 +7.2% $212.59
2024-04-05 Deutsche Bank Brian Bedell $212 $210 -2 -1.0% $212.21
2023-02-07 Credit Suisse $210 $198 -12 +13.3% $174.76
2023-01-11 Morgan Stanley $226 $196 -30 +10.8% $176.93
2022-12-19 Piper Sandler $230 $250 +20 +46.1% $171.12
2022-09-06 Credit Suisse $216 $210 -6 +7.9% $194.69
2022-08-17 Rosenblatt Securities Initiated $171 -16.8% $205.46
2022-08-12 Deutsche Bank $213 $212 -1 +4.9% $202.15
2022-08-03 Credit Suisse $218 $216 -2 +9.0% $198.25
2022-08-02 UBS $246 $240 -6 +22.9% $195.34
2022-07-28 Morgan Stanley $242 $226 -16 +13.9% $198.50
2022-07-28 Credit Suisse $233 $218 -15 +11.2% $195.99
2022-07-19 Morgan Stanley Initiated $242 +20.1% $201.51
2022-07-13 Deutsche Bank $210 $213 +3 +4.6% $203.55
2022-07-06 Credit Suisse $259 $233 -26 +14.0% $204.36
2022-07-06 UBS $258 $246 -12 +20.4% $204.36
2022-07-06 Raymond James $254 $235 -19 +15.0% $204.36
2022-06-10 Atlantic Equities Simon Clinch Initiated $235 +17.2% $200.43
2022-06-03 UBS $269 $258 -11 +26.1% $204.68
2022-05-19 Deutsche Bank Initiated $210 +10.4% $190.15
2022-05-16 Argus Research Stephen Biggar Initiated $230 +14.9% $200.10

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
4
ROE
4
ROA
4
D/E
3
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CME receives an overall rating of B. Strongest factors: DCF (4/5), ROE (4/5), ROA (4/5). Areas of concern: P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-11 B+ B
2026-04-24 A- B+
2026-04-22 B+ A-
2026-04-01 B B+
2026-03-30 B+ B
2026-03-04 B B+
2026-03-02 B+ B
2026-02-20 B B+
2026-02-05 C- B
2026-02-04 B C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

59 Grade A+
Profitability
75
Balance Sheet
62
Earnings Quality
85
Growth
57
Value
59
Momentum
78
Safety
80
Cash Flow
86
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CME scores highest in Cash Flow (86/100) and lowest in Growth (57/100). An overall grade of A+ places CME among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman-B Score
3.21
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-1.08
Possible Manipulator
Ohlson O-Score
-6.93
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
AA
Score: 87.1/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.04x
Accruals: -0.1%
The Altman-B Score replaces the traditional Z-Score for banks and financial institutions. It weights equity-to-assets, return on assets, retained earnings, market value coverage, and cash reserves — metrics that better capture bank solvency than manufacturing-oriented ratios. CME scores 3.21, placing it in the Safe Zone (safe > 3.0, distress < 1.5). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CME scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CME's score of -1.08 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CME's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CME receives an estimated rating of AA (score: 87.1/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CME's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
24.67x
PEG
1.34x
P/S
15.61x
P/B
3.93x
P/FCF
24.78x
P/OCF
24.27x
EV/EBITDA
18.72x
EV/Revenue
15.76x
EV/EBIT
19.47x
EV/FCF
24.60x
Earnings Yield
3.95%
FCF Yield
4.04%
Shareholder Yield
4.55%
Graham Number
$144.18
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 24.7x earnings, CME commands a growth premium. Graham's intrinsic value formula yields $144.18 per share, 102% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.758
NI / EBT
×
Interest Burden
1.023
EBT / EBIT
×
EBIT Margin
0.809
EBIT / Rev
×
Asset Turnover
0.040
Rev / Assets
×
Equity Multiplier
6.085
Assets / Equity
=
ROE
15.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CME's ROE of 15.4% is driven by financial leverage (equity multiplier: 6.09x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
13.59%
Fair P/E
35.68x
Intrinsic Value
$416.72
Price/Value
0.71x
Margin of Safety
29.12%
Premium
-29.12%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CME's realized 13.6% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $416.72, CME appears undervalued with a 29% margin of safety. The adjusted fair P/E of 35.7x compares to the current market P/E of 24.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$291.23
Median 1Y
$316.15
5th Pctile
$207.70
95th Pctile
$482.82
Ann. Volatility
26.0%
Analyst Target
$343.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Lynne C. Fitzpatrick
President and Chief Financial Officer
$750,000 $2,497,729 $4,752,142
Derek L. Sammann
Global Head of Commodities Markets
$525,000 $1,748,451 $3,390,974
Julie M. Winkler
Chief Commercial Officer
$525,000 $1,748,451 $3,379,744
Sunil K. Cutinho
Chief Information Officer
$525,000 $1,748,451 $3,376,706

CEO Pay Ratio

617:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $23,945,589
Avg Employee Cost (SGA/emp): $38,839
Employees: 3,875

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,875
+3.1% YoY
Revenue / Employee
$1,682,735
Rev: $6,520,600,000
Profit / Employee
$1,043,716
NI: $4,044,400,000
SGA / Employee
$38,839
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 7.3% 9.3% 9.8% 10.3% 10.9% 10.0% 9.9% 10.6% 11.0% 11.2% 12.0% 11.9% 12.3% 12.9% 13.2% 13.6% 14.1% 14.1% 14.6% 15.4% 15.37%
ROA 1.9% 2.4% 1.6% 1.7% 1.8% 1.7% 1.5% 1.5% 1.6% 1.6% 2.1% 2.1% 2.2% 2.3% 2.6% 2.7% 2.8% 2.8% 2.4% 2.5% 2.53%
ROIC 6.6% 7.1% 7.4% 7.8% 8.1% 8.3% 8.5% 8.6% 8.8% 9.0% 9.8% 10.0% 10.4% 11.0% 11.3% 11.8% 12.2% 12.0% 11.5% 12.1% 12.06%
ROCE 7.5% 9.0% 9.7% 10.2% 10.6% 10.0% 10.0% 10.7% 11.1% 11.3% 11.9% 11.8% 12.1% 12.7% 13.4% 13.8% 14.3% 14.3% 2.7% 2.8% 2.76%
Gross Margin 82.0% 82.1% 82.4% 86.2% 85.0% 84.6% 84.0% 85.8% 84.9% 84.6% 85.2% 86.2% 86.6% 86.2% 85.5% 87.4% 86.9% 84.5% 85.4% 88.1% 88.14%
Operating Margin 57.2% 55.3% 55.1% 63.8% 60.6% 60.2% 55.3% 63.4% 61.7% 61.3% 60.0% 64.5% 65.3% 64.6% 62.1% 67.5% 66.7% 63.3% 61.8% 69.7% 69.66%
Net Margin 43.3% 83.5% 54.5% 52.8% 53.5% 55.4% 52.8% 61.3% 57.2% 56.1% 56.6% 57.5% 57.6% 57.6% 57.3% 58.2% 59.8% 59.1% 70.8% 61.4% 61.40%
EBITDA Margin 73.3% 1.1% 81.6% 78.0% 80.6% 82.3% 79.3% 89.2% 84.2% 82.4% 78.6% 83.2% 83.4% 82.1% 80.0% 83.4% 86.2% 84.8% 96.4% 71.1% 71.11%
FCF Margin 40.9% 47.9% 48.5% 51.8% 54.0% 53.4% 59.1% 60.2% 59.3% 61.9% 60.5% 59.8% 60.2% 60.0% 58.7% 60.9% 63.7% 63.8% 64.3% 64.1% 64.06%
OCF Margin 45.0% 51.6% 51.2% 54.3% 56.1% 55.3% 60.9% 61.8% 60.9% 63.4% 61.9% 61.2% 61.6% 61.5% 60.2% 62.3% 65.1% 65.0% 65.6% 65.4% 65.41%
ROE 3Y Avg snapshot only 13.47%
ROE 5Y Avg snapshot only 12.24%
ROA 3Y Avg snapshot only 2.41%
ROIC 3Y Avg snapshot only 10.81%
ROIC Economic snapshot only 10.42%
Cash ROA snapshot only 2.23%
Cash ROIC snapshot only 15.82%
CROIC snapshot only 15.50%
NOPAT Margin snapshot only 49.85%
Pretax Margin snapshot only 82.81%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 2.22%
SBC / Revenue snapshot only 1.41%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 33.16 23.89 26.55 26.41 21.66 20.58 20.07 21.62 20.23 21.49 22.02 22.84 20.30 21.84 23.27 25.98 26.19 25.84 24.32 25.29 24.666
P/S Ratio 13.81 12.54 14.93 15.31 13.09 11.11 10.76 12.10 11.51 12.25 12.73 12.98 11.57 12.52 13.39 15.00 15.27 15.15 15.09 15.87 15.615
P/B Ratio 2.42 2.21 2.55 2.67 2.31 2.01 2.01 2.30 2.24 2.44 2.66 2.73 2.51 2.83 3.10 3.56 3.71 3.66 3.42 3.73 3.931
P/FCF 33.73 26.16 30.77 29.57 24.22 20.80 18.21 20.11 19.39 19.79 21.03 21.71 19.21 20.86 22.81 24.63 23.95 23.73 23.46 24.78 24.778
P/OCF 30.70 24.30 29.14 28.19 23.32 20.09 17.67 19.59 18.88 19.32 20.56 21.20 18.78 20.36 22.23 24.07 23.45 23.29 23.00 24.27 24.268
EV/EBITDA 20.76 16.24 17.96 18.05 15.14 13.92 13.60 14.71 13.84 14.73 15.31 15.90 14.20 15.37 16.37 18.31 18.47 18.19 17.06 18.72 18.720
EV/Revenue 14.18 12.91 15.03 15.42 13.19 11.21 10.88 12.23 11.63 12.37 12.80 13.05 11.64 12.59 13.45 15.06 15.33 15.21 14.97 15.76 15.756
EV/EBIT 24.07 18.28 19.91 19.90 16.61 15.33 14.95 16.07 15.07 16.00 16.56 17.20 15.31 16.50 17.54 19.58 19.70 19.39 17.92 19.47 19.472
EV/FCF 34.64 26.92 30.99 29.77 24.41 20.98 18.42 20.32 19.59 19.98 21.15 21.83 19.32 20.97 22.93 24.74 24.05 23.83 23.27 24.60 24.596
Earnings Yield 3.0% 4.2% 3.8% 3.8% 4.6% 4.9% 5.0% 4.6% 4.9% 4.7% 4.5% 4.4% 4.9% 4.6% 4.3% 3.8% 3.8% 3.9% 4.1% 4.0% 3.95%
FCF Yield 3.0% 3.8% 3.3% 3.4% 4.1% 4.8% 5.5% 5.0% 5.2% 5.1% 4.8% 4.6% 5.2% 4.8% 4.4% 4.1% 4.2% 4.2% 4.3% 4.0% 4.04%
PEG Ratio snapshot only 1.344
EV/OCF snapshot only 24.089
EV/Gross Profit snapshot only 18.249
Acquirers Multiple snapshot only 24.030
Shareholder Yield snapshot only 4.55%
Graham Number snapshot only $144.18
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.02 1.02 1.02 1.01 1.01 1.01 1.01 92.97 92.97 92.968
Quick Ratio 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.02 1.02 1.02 1.01 1.01 1.01 1.01 92.97 92.97 92.968
Debt/Equity 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.131
Net Debt/Equity 0.06 0.06 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 -0.03 -0.03 -0.028
Debt/Assets 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.019
Debt/EBITDA 1.09 0.93 0.88 0.84 0.82 0.86 0.86 0.81 0.78 0.77 0.73 0.74 0.72 0.69 0.68 0.66 0.64 0.64 0.66 0.66 0.661
Net Debt/EBITDA 0.54 0.46 0.13 0.12 0.12 0.12 0.15 0.15 0.14 0.14 0.09 0.09 0.08 0.08 0.08 0.08 0.08 0.08 -0.14 -0.14 -0.139
Interest Coverage 16.31 19.65 21.21 22.07 23.14 22.02 22.45 24.30 25.19 25.91 27.06 26.78 27.67 28.83 29.22 29.72 30.10 29.45 41.98 41.55 41.554
Equity Multiplier 4.74 4.74 7.18 7.18 7.18 7.18 6.48 6.48 6.48 6.48 4.85 4.85 4.85 4.85 5.19 5.19 5.19 5.19 6.91 6.91 6.911
Cash Ratio snapshot only 81.513
Debt Service Coverage snapshot only 43.223
Cash to Debt snapshot only 1.211
FCF to Debt snapshot only 1.152
Defensive Interval snapshot only 1348.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.05 0.05 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.05 0.04 0.04 0.040
Inventory Turnover
Receivables Turnover 9.68 9.74 10.47 10.68 10.81 11.07 10.94 11.15 11.41 11.65 10.95 11.04 11.38 11.87 11.06 11.34 11.62 11.54 10.76 11.15 11.150
Payables Turnover 13.24 12.97 14.17 13.50 13.05 12.90 8.85 9.08 9.32 9.50 7.82 7.83 7.82 7.95 9.97 9.98 10.18 10.40 11.96 12.17 12.173
DSO 38 37 35 34 34 33 33 33 32 31 33 33 32 31 33 32 31 32 34 33 32.7 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 28 28 26 27 28 28 41 40 39 38 47 47 47 46 37 37 36 35 31 30 30.0 days
Cash Conversion Cycle 10 9 9 7 6 5 -8 -7 -7 -7 -13 -14 -15 -15 -4 -4 -4 -3 3 3 2.8 days
Fixed Asset Turnover snapshot only 11.795
Cash Velocity snapshot only 1.486
Capital Intensity snapshot only 29.378
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -9.9% -5.7% -4.0% 3.6% 5.0% 6.9% 7.0% 6.9% 8.2% 7.8% 11.1% 10.0% 10.7% 13.0% 9.9% 11.7% 11.2% 5.8% 6.4% 7.5% 7.54%
Net Income -19.2% 13.2% 25.2% 44.9% 52.3% 10.0% 2.1% 3.3% 1.8% 13.9% 19.9% 11.7% 10.9% 13.7% 9.3% 13.4% 13.7% 8.2% 14.7% 17.0% 16.98%
EPS -19.2% 13.1% 25.1% 44.8% 52.2% 9.9% 2.0% 3.2% 1.8% 13.8% 19.7% 11.5% 10.8% 13.5% 9.2% 13.3% 13.6% 8.1% 14.7% 16.0% 16.02%
FCF -38.5% -13.8% -9.6% 4.2% 38.6% 19.1% 30.4% 24.3% 18.8% 24.9% 13.9% 9.3% 12.4% 9.6% 6.5% 13.8% 17.6% 12.6% 16.6% 13.2% 13.15%
EBITDA -13.2% 7.3% 17.1% 31.7% 33.9% 8.3% 2.3% 4.1% 4.3% 12.5% 16.2% 8.7% 8.0% 10.2% 8.0% 11.9% 12.6% 8.1% 13.5% 10.0% 10.03%
Op. Income -14.6% -6.2% 0.3% 15.7% 17.0% 17.8% 14.0% 10.5% 10.7% 8.8% 13.9% 13.4% 15.3% 18.7% 14.4% 17.2% 15.5% 8.0% 7.6% 8.6% 8.61%
OCF Growth snapshot only 12.93%
Asset Growth snapshot only 44.45%
Equity Growth snapshot only 8.46%
Debt Growth snapshot only 9.60%
Shares Change snapshot only 0.83%
Dividend Growth snapshot only 6.28%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 5.2% 5.3% 2.9% 3.0% 1.8% -0.0% 1.0% -0.6% 0.8% 2.8% 4.5% 6.8% 7.9% 9.2% 9.3% 9.5% 10.0% 8.9% 9.1% 9.7% 9.74%
Revenue 5Y 5.6% 5.8% 5.5% 5.9% 6.1% 6.3% 6.6% 6.0% 5.8% 6.1% 5.3% 5.1% 4.8% 4.0% 4.7% 3.8% 4.7% 5.4% 6.0% 7.9% 7.93%
EPS 3Y -25.5% -20.0% 9.6% 14.1% 17.3% 9.5% 8.2% 6.2% 7.7% 12.2% 15.2% 18.6% 19.7% 12.4% 10.1% 9.3% 8.6% 11.8% 14.4% 13.6% 13.59%
EPS 5Y 6.2% 9.6% 10.2% 10.9% 10.8% 11.1% -8.9% -8.6% -8.5% -8.5% 10.0% 11.3% 12.7% 11.2% 10.6% 8.6% 9.5% 11.7% 13.8% 17.0% 16.98%
Net Income 3Y -24.2% -18.6% 10.3% 14.2% 17.4% 9.6% 8.3% 6.3% 7.8% 12.3% 15.3% 18.7% 19.8% 12.5% 10.2% 9.4% 8.7% 11.9% 14.5% 14.0% 14.00%
Net Income 5Y 7.5% 10.9% 11.4% 12.1% 12.0% 12.3% -7.9% -7.6% -7.6% -7.6% 10.5% 11.4% 12.8% 11.3% 10.7% 8.7% 9.6% 11.8% 13.9% 17.3% 17.26%
EBITDA 3Y 1.0% 6.8% 7.2% 9.4% 10.3% 5.8% 6.3% 4.9% 6.6% 9.3% 11.6% 14.2% 14.7% 10.3% 8.7% 8.2% 8.2% 10.2% 12.5% 10.2% 10.20%
EBITDA 5Y 5.0% 8.0% 8.3% 8.2% 8.3% 6.8% 7.1% 7.7% 7.6% 8.2% 7.9% 8.2% 8.6% 8.0% 8.6% 7.0% 8.1% 9.3% 11.3% 12.9% 12.89%
Gross Profit 3Y 3.6% 3.9% 1.8% 3.0% 2.5% 1.0% 2.4% 0.1% 1.5% 3.7% 5.7% 8.6% 9.9% 11.1% 11.1% 10.9% 11.1% 9.5% 9.6% 10.4% 10.35%
Gross Profit 5Y 4.9% 5.2% 4.9% 5.8% 6.1% 6.5% 6.9% 6.1% 5.7% 6.1% 5.4% 5.6% 5.6% 5.0% 5.9% 4.6% 5.6% 6.3% 6.9% 9.3% 9.30%
Op. Income 3Y -1.0% 0.4% 0.5% 3.6% 4.1% 3.8% 5.2% 1.7% 3.4% 6.3% 9.2% 13.2% 14.3% 15.0% 14.1% 13.7% 13.8% 11.7% 11.9% 13.0% 13.01%
Op. Income 5Y 2.8% 3.5% 3.7% 4.5% 4.7% 5.2% 5.5% 4.6% 4.7% 5.4% 5.7% 6.9% 7.6% 7.6% 8.7% 6.9% 8.1% 9.1% 9.9% 13.0% 13.02%
FCF 3Y -6.3% -1.8% -0.7% 5.0% 8.9% 5.9% 6.9% 6.9% 0.4% 8.7% 10.3% 12.2% 22.8% 17.7% 16.5% 15.6% 16.2% 15.5% 12.2% 12.0% 12.04%
FCF 5Y 4.9% 8.3% 7.0% 8.8% 8.9% 8.5% 11.0% 8.3% 6.3% 7.1% 7.8% 9.5% 11.5% 10.2% 8.2% 8.7% 6.0% 9.6% 10.7% 12.7% 12.73%
OCF 3Y -4.3% -0.6% -0.5% 4.4% 6.7% 3.6% 4.6% 4.6% -0.8% 6.9% 8.3% 10.4% 19.8% 15.8% 15.4% 14.6% 15.6% 14.9% 11.9% 11.8% 11.85%
OCF 5Y 5.6% 8.7% 7.0% 8.7% 8.6% 8.3% 10.7% 8.0% 6.2% 6.8% 7.2% 8.6% 9.8% 8.6% 6.7% 7.2% 5.1% 8.4% 9.5% 11.5% 11.53%
Assets 3Y 18.0% 18.0% 36.4% 36.4% 36.4% 36.4% 32.3% 32.3% 32.3% 32.3% 1.3% 1.3% 1.3% 1.3% -11.3% -11.3% -11.3% -11.3% 4.5% 4.5% 4.46%
Assets 5Y 13.1% 13.1% 23.2% 23.2% 23.2% 23.2% 18.1% 18.1% 18.1% 18.1% 10.9% 10.9% 10.9% 10.9% 12.8% 12.8% 12.8% 12.8% 9.8% 9.8% 9.76%
Equity 3Y 5.5% 5.5% 1.9% 1.9% 1.9% 1.9% 0.9% 0.9% 0.9% 0.9% 0.5% 0.5% 0.5% 0.5% -1.1% -1.1% -1.1% -1.1% 2.2% 2.2% 2.24%
Book Value 3Y 3.7% 3.7% 1.2% 1.8% 1.8% 1.8% 0.9% 0.9% 0.9% 0.9% 0.4% 0.4% 0.4% 0.4% -1.2% -1.2% -1.2% -1.2% 2.1% 1.9% 1.88%
Dividend 3Y 0.0% -0.2% 0.6% 5.6% 5.9% 6.1% 6.3% 7.4% 7.3% 7.1% 7.0% 4.0% 3.8% 3.6% 3.4% 2.6% 2.8% 2.9% 3.0% 1.7% 1.68%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.76 0.70 0.76 0.59 0.61 0.57 0.68 0.51 0.62 0.83 0.83 0.89 0.78 0.56 0.70 0.51 0.66 0.84 0.90 0.96 0.963
Earnings Stability 0.01 0.04 0.00 0.00 0.00 0.00 0.11 0.08 0.06 0.09 0.90 0.79 0.81 0.97 0.94 0.82 0.83 0.99 0.97 0.95 0.955
Margin Stability 0.98 0.98 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.974
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.92 0.95 0.90 0.82 0.50 0.96 0.99 0.99 0.99 0.94 0.92 0.95 0.96 0.95 0.96 0.95 0.95 0.97 0.94 0.93 0.932
Earnings Smoothness 0.79 0.88 0.78 0.63 0.59 0.90 0.98 0.97 0.98 0.87 0.82 0.89 0.90 0.87 0.91 0.87 0.87 0.92 0.86 0.84 0.844
ROE Trend -0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.019
Gross Margin Trend -0.02 -0.01 0.00 0.01 0.02 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.005
FCF Margin Trend -0.11 -0.01 -0.02 0.02 0.04 0.03 0.09 0.09 0.12 0.11 0.07 0.04 0.04 0.02 -0.01 0.01 0.04 0.03 0.05 0.04 0.037
Sustainable Growth Rate -0.9% 1.0% 1.7% 1.0% 1.4% 0.3% 0.2% -1.0% -0.7% -0.6% -0.0% -1.2% -0.9% -0.4% -0.2% -0.7% -0.4% -0.5% 0.4% 0.6% 0.65%
Internal Growth Rate 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% 0.1% 0.1% 0.11%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.08 0.98 0.91 0.94 0.93 1.02 1.14 1.10 1.07 1.11 1.07 1.08 1.08 1.07 1.05 1.08 1.12 1.11 1.06 1.04 1.042
FCF/OCF 0.91 0.93 0.95 0.95 0.96 0.97 0.97 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.98 0.98 0.979
FCF/Net Income snapshot only 1.020
OCF/EBITDA snapshot only 0.777
CapEx/Revenue 4.0% 3.7% 2.7% 2.6% 2.1% 1.9% 1.8% 1.6% 1.6% 1.5% 1.4% 1.4% 1.4% 1.5% 1.5% 1.4% 1.4% 1.2% 1.3% 1.3% 1.35%
CapEx/Depreciation snapshot only 0.415
Accruals Ratio -0.00 0.00 0.00 0.00 0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.001
Sloan Accruals snapshot only 0.025
Cash Flow Adequacy snapshot only 1.064
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 3.4% 3.7% 3.1% 3.4% 4.0% 4.7% 4.9% 5.0% 5.2% 4.9% 4.6% 4.8% 5.3% 4.7% 4.4% 4.1% 3.9% 4.0% 4.0% 3.8% 3.85%
Dividend/Share $5.99 $6.04 $6.10 $7.00 $7.12 $7.23 $7.33 $8.70 $8.80 $8.90 $9.00 $9.81 $9.86 $9.90 $9.95 $10.61 $10.71 $10.81 $10.92 $11.19 $11.20
Payout Ratio 1.1% 89.0% 83.0% 90.7% 87.4% 97.0% 97.9% 1.1% 1.1% 1.0% 1.0% 1.1% 1.1% 1.0% 1.0% 1.1% 1.0% 1.0% 97.2% 95.8% 95.77%
FCF Payout Ratio 1.1% 97.4% 96.2% 1.0% 97.7% 98.0% 88.8% 1.0% 1.0% 96.6% 95.8% 1.0% 1.0% 98.3% 99.7% 99.9% 94.0% 95.4% 93.8% 93.9% 93.85%
Total Payout Ratio 1.1% 90.4% 84.2% 91.5% 88.2% 97.8% 98.8% 1.1% 1.1% 1.1% 1.0% 1.1% 1.1% 1.0% 1.0% 1.1% 1.0% 1.0% 1.0% 1.1% 1.15%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.09 0.08 0.07 0.22 0.23 0.25 0.25 0.29 0.29 0.28 0.27 0.18 0.17 0.16 0.15 0.12 0.13 0.13 0.14 0.10 0.101
Buyback Yield 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.8% 0.76%
Net Buyback Yield 0.1% 0.1% -1.3% -1.3% -1.5% -1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.8% 0.76%
Total Shareholder Return 3.4% 3.8% 1.8% 2.1% 2.5% 3.0% 4.9% 5.1% 5.3% 4.9% 4.6% 4.9% 5.3% 4.8% 4.4% 4.1% 4.0% 4.1% 4.3% 4.5% 4.55%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.75 0.78 0.78 0.78 0.80 0.77 0.77 0.77 0.77 0.77 0.78 0.78 0.78 0.78 0.78 0.78 0.77 0.77 0.76 0.76 0.758
Interest Burden (EBT/EBIT) 0.94 0.95 0.95 0.95 0.96 0.95 0.96 0.96 0.96 0.96 0.96 0.96 0.96 0.97 0.97 0.97 0.97 0.97 0.98 1.02 1.023
EBIT Margin 0.59 0.71 0.75 0.77 0.79 0.73 0.73 0.76 0.77 0.77 0.77 0.76 0.76 0.76 0.77 0.77 0.78 0.78 0.84 0.81 0.809
Asset Turnover 0.05 0.05 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.05 0.04 0.04 0.040
Equity Multiplier 3.81 3.81 5.98 5.98 5.98 5.98 6.83 6.83 6.83 6.83 5.67 5.67 5.67 5.67 5.02 5.02 5.02 5.02 6.09 6.09 6.085
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $5.35 $6.78 $7.34 $7.72 $8.14 $7.45 $7.49 $7.97 $8.29 $8.48 $8.97 $8.89 $9.18 $9.63 $9.79 $10.07 $10.42 $10.41 $11.23 $11.68 $11.68
Book Value/Share $73.34 $73.32 $76.32 $76.28 $76.28 $76.26 $74.83 $74.81 $74.78 $74.74 $74.34 $74.31 $74.30 $74.27 $73.56 $73.53 $73.51 $73.51 $79.75 $79.10 $74.08
Tangible Book/Share $-18.17 $-18.16 $-10.68 $-10.68 $-10.68 $-10.68 $-11.27 $-11.27 $-11.26 $-11.26 $-11.07 $-11.07 $-11.07 $-11.06 $-11.10 $-11.10 $-11.09 $-11.09 $-4.37 $-4.33 $-4.33
Revenue/Share $12.85 $12.93 $13.06 $13.32 $13.48 $13.80 $13.97 $14.23 $14.57 $14.87 $15.51 $15.63 $16.11 $16.79 $17.03 $17.45 $17.89 $17.75 $18.10 $18.61 $18.81
FCF/Share $5.26 $6.20 $6.34 $6.90 $7.28 $7.38 $8.26 $8.57 $8.65 $9.21 $9.39 $9.35 $9.70 $10.08 $9.99 $10.62 $11.40 $11.33 $11.64 $11.92 $12.05
OCF/Share $5.78 $6.67 $6.69 $7.24 $7.56 $7.63 $8.51 $8.79 $8.88 $9.43 $9.60 $9.57 $9.92 $10.33 $10.25 $10.87 $11.65 $11.55 $11.87 $12.17 $12.30
Cash/Share $4.83 $4.83 $8.22 $8.21 $8.21 $8.21 $7.84 $7.84 $7.83 $7.83 $8.41 $8.40 $8.40 $8.40 $8.35 $8.34 $8.34 $8.34 $12.63 $12.52 $7.00
EBITDA/Share $8.78 $10.27 $10.94 $11.37 $11.74 $11.12 $11.18 $11.83 $12.24 $12.49 $12.97 $12.84 $13.20 $13.75 $14.00 $14.35 $14.84 $14.85 $15.88 $15.66 $15.66
Debt/Share $9.60 $9.59 $9.60 $9.59 $9.59 $9.59 $9.57 $9.57 $9.57 $9.56 $9.52 $9.52 $9.52 $9.52 $9.52 $9.52 $9.51 $9.51 $10.43 $10.34 $10.34
Net Debt/Share $4.76 $4.76 $1.38 $1.38 $1.38 $1.38 $1.73 $1.73 $1.73 $1.73 $1.12 $1.12 $1.12 $1.12 $1.17 $1.17 $1.17 $1.17 $-2.20 $-2.18 $-2.18
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman-B Score 3.210
Altman Z-Prime snapshot only 1.124
Piotroski F-Score 5 4 4 5 5 5 7 6 6 7 7 7 7 7 7 7 7 6 5 6 6
Beneish M-Score -2.53 -2.56 -2.50 -2.54 -2.54 -2.52 -2.41 -2.40 -2.39 -2.35 -2.33 -2.34 -2.35 -2.34 -2.41 -2.40 -2.44 -2.46 -1.15 -1.08 -1.079
Ohlson O-Score snapshot only -6.925
Net-Net WC snapshot only $-453.27
EVA snapshot only $575582864.60
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA
Credit Score 77.18 80.74 71.69 74.63 74.68 73.70 72.81 77.06 76.23 75.36 86.90 85.63 86.80 86.19 86.41 86.33 91.20 86.38 82.98 87.08 87.078
Credit Grade snapshot only 3
Credit Trend snapshot only 0.747
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 69
Sector Credit Rank snapshot only 89

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms